Trial Profile
Effect of ROsuvastatin Therapy on Peripheral Vasodilator Function, Inflammatory Markers and Pulmonary Function in Patients With StablE Chronic Obstructive Pulmonary Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacodynamics
- Acronyms RODEO
- 01 Jul 2015 Results published in the Journal of Internal Medicine.
- 29 Jan 2014 According to ClinicalTrials.gov record study status changed to completed.
- 26 Apr 2012 Additional lead trial centre (Haukeland University Hospital) identified as reported by ClinicalTrials.gov.